Table 1 Clinical characteristics of 273 study participants
Variable | n (%) |
|---|---|
Age, years, mean ± SD | 51.0 ± 16.0 |
Male sex (%) | 161 (59.0) |
BMI, kg/m2 | 22.72 ± 4.62 |
Disease extent (pancolitis/left-sided/proctitis/others) | 113/74/79/7 |
Disease duration, years, median ± IQR | 7.0 ± 11.0 |
Medication | |
5-aminosalicylates (%) | 249 (91.2) |
Prednisolone (%) | 59 (21.6) |
TNF-α monoclonal antibody (%) | 17 (6.2) |
Azathioprine (%) | 41 (15.0) |
Clinical remission, % | 158 (57.9) |
MES, mean ± SD | 1.18 ± 0.91 |
MES 0, n (%) | 71 (26.0) |
MES 1, n (%) | 101 (37.0) |
MES 2, n (%) | 81 (29.7) |
MES 3, n (%) | 20 (7.3) |
Mucosal healing (MES = 0) (%) | 71 (26.0) |
Moderate to severe UC (MES 2 or MES 3) | 101 (37.0) |
Albumin, g/dl, mean ± SD | 4.218 ± 0.43 |
CRP, mg/dl, median ± IQR | 0.099 ± 0.23 |
CAR, median ± IQR | 0.022 ± 0.053 |